Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci. | JCI Insight | 2022 | 35050902 | PubTator, text mining | PubMed |
| Inflammatory activation and immune cell infiltration are main biological characteristics of SARS-CoV-2 infected myocardium. | Bioengineered | 2022 | 35037831 | PubTator, text mining | PubMed |
| ETS factors in prostate cancer. | Cancer Lett | 2022 | 35033589 | PubTator, text mining | PubMed |
| Differential roles of BAF and PBAF subunits, Arid1b and Arid2, in MLL-AF9 leukemogenesis. | Leukemia | 2022 | 35022500 | PubTator, text mining | PubMed |
| Olive oil intake and cancer risk: A systematic review and meta-analysis. | PLoS One | 2022 | 35015763 | PubTator, text mining | PubMed |
| Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. | Nat Commun | 2022 | 35013146 | PubTator, text mining | PubMed |
| Analysis of a large prostate cancer family identifies novel and recurrent gene fusion events providing evidence for inherited predisposition. | Prostate | 2022 | 34994974 | PubTator, text mining | PubMed |
| Y chromosome is moving out of sex determination shadow. | Cell Biosci | 2022 | 34983649 | PubTator, text mining | PubMed |
| Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options. | World J Mens Health | 2022 | 34983086 | PubTator, text mining | PubMed |
| Knockdown of ETV4 promotes autophagy-dependent apoptosis in GBM cells by reducing the transcriptional activation of EMP1. | Oncol Lett | 2022 | 34976153 | PubTator, text mining | PubMed |
| Multi-omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID-19. | J Cell Mol Med | 2022 | 34951103 | PubTator, text mining | PubMed |
| Identification of key genes and carcinogenic pathways in hepatitis B virus-associated hepatocellular carcinoma through bioinformatics analysis. | Ann Hepatobiliary Pancreat Surg | 2022 | 34907098 | PubTator, text mining | PubMed |
| Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma. | Cancer Res | 2022 | 34903601 | PubTator, text mining | PubMed |
| Autophagy ATG16L1 rs2241880 impacts the colorectal cancer risk: A case-control study. | J Clin Lab Anal | 2022 | 34894411 | PubTator, text mining | PubMed |
| Chondroprotective effects of CDK4/6 inhibition via enhanced ubiquitin-dependent degradation of JUN in synovial fibroblasts. | Rheumatology (Oxford) | 2022 | 34849618 | PubTator, text mining | PubMed |
| Generation and characterization of stable pig pregastrulation epiblast stem cell lines. | Cell Res | 2022 | 34848870 | PubTator, text mining | PubMed |
| Mutant p53 elicits context-dependent pro-tumorigenic phenotypes. | Oncogene | 2022 | 34773073 | PubTator, text mining | PubMed |
| Integrative multi-omic analysis reveals neurodevelopmental gene dysregulation in CIC-knockout and IDH1-mutant cells. | J Pathol | 2022 | 34767259 | PubTator, text mining | PubMed |
| Bioinformatics screening of ETV4 transcription factor oncogenes and identifying small-molecular anticancer drugs. | Chem Biol Drug Des | 2022 | 34757684 | PubTator, text mining | PubMed |
| Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis. | Ann Rheum Dis | 2022 | 34750102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=34